Kassie Adamu, Berta Dereje Mengesha, Yalew Aregawi, Sitotaw Chomaw, Workineh Mickael, Woldu Berhanu
Department of Medical Laboratory, College of Medicine and Health Science, Dilla University, Dilla, Ethiopia.
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
BMC Pediatr. 2025 Feb 14;25(1):115. doi: 10.1186/s12887-025-05464-4.
Phototherapy is a common treatment for neonatal hyperbilirubinemia, however it generates reactive oxygen species and induces apoptosis, potentially influencing blood cells. Assessing changes in hematological parameters is essential to minimize complications and enhance outcomes.
This study assessed hematological parameters changes and associated factors in neonates with hyperbilirubinemia undergoing phototherapy.
A cross-sectional study was conducted at the University of Gondar Comprehensive Specialized Hospital from May 29 to November 8, 2023. About 246 neonates were selected by convenient sampling. Blood samples were collected before and after phototherapy. Data were entered into Epi-data (4.6.0) and analyzed using SPSS (25.0). The normality of the data was checked by Kolmogorov-Smirnov tests. A paired t-test and Wilcoxon Sign Rank test were used to compare mean differences for normally distributed and skewed data, respectively. Pearson correlation and multiple linear regressions were used to measure the association. A significance level of p < 0.05 was used for statistical significance.
Among neonates, 141 (57.3%) were males, and the median age was 2 days. Phototherapy treatment led to significant increases in WBC and lymphocyte count, 11.02 ± 2.21 to 11.35 ± 2.60, and 3.93 ± 1.19 to 4.16 ± 1.34, respectively. However, hemoglobin and platelet count significantly decreased from 15.05 ± 3.67 to 14.55 ± 2.62, and 243.23 ± 74.78 to 239.32 ± 73.29, respectively. Other blood cell parameters were unaffected. WBC and lymphocytes showed a positive association with preterm neonates and intensive phototherapy, while WBC count showed a negative association with total bilirubin. Hemoglobin counts are positively associated with total bilirubin but negatively associated with neonate age and treatment duration. Platelet count showed negative associations with low-birth-weight neonates, intensive phototherapy, and treatment duration. After treatment, normocytic normochromic cells increased, microcytic hypochromic decreased, and abnormal RBC shapes were reduced.
Phototherapy significantly affected key hematological parameters, notably WBC, lymphocytes, hemoglobin, and platelet count. Treating neonates with intensive phototherapy affects WBC and platelet counts while undergoing phototherapy for a longer duration affects hemoglobin and platelet counts. Therefore, routine monitoring of these parameters is crucial for neonates undergoing intensive or prolonged phototherapy.
光疗是新生儿高胆红素血症的常见治疗方法,然而它会产生活性氧并诱导细胞凋亡,可能影响血细胞。评估血液学参数的变化对于将并发症降至最低并改善治疗效果至关重要。
本研究评估了接受光疗的高胆红素血症新生儿的血液学参数变化及相关因素。
于2023年5月29日至11月8日在贡德尔大学综合专科医院进行了一项横断面研究。通过方便抽样选取了约246名新生儿。在光疗前后采集血样。数据录入Epi - data(4.6.0)并使用SPSS(25.0)进行分析。通过Kolmogorov - Smirnov检验检查数据的正态性。分别使用配对t检验和Wilcoxon符号秩检验来比较正态分布和偏态数据的均值差异。使用Pearson相关性和多元线性回归来衡量相关性。以p < 0.05的显著性水平作为统计学显著性标准。
在新生儿中,141名(57.3%)为男性,中位年龄为2天。光疗导致白细胞(WBC)和淋巴细胞计数显著增加,分别从11.02 ± 2.21增至11.35 ± 2.60,以及从3.93 ± 1.19增至4.16 ± 1.34。然而,血红蛋白和血小板计数分别从15.05 ± 3.67显著降至14.55 ± 2.62,以及从243.23 ± 74.78降至239.32 ± 73.29。其他血细胞参数未受影响。白细胞和淋巴细胞与早产儿及强化光疗呈正相关,而白细胞计数与总胆红素呈负相关。血红蛋白计数与总胆红素呈正相关,但与新生儿年龄和治疗持续时间呈负相关。血小板计数与低体重新生儿、强化光疗及治疗持续时间呈负相关。治疗后,正细胞正色素性细胞增加,小细胞低色素性细胞减少,异常红细胞形态减少。
光疗显著影响关键血液学参数,尤其是白细胞、淋巴细胞、血红蛋白和血小板计数。对新生儿进行强化光疗会影响白细胞和血小板计数,而光疗持续时间较长会影响血红蛋白和血小板计数。因此,对于接受强化或长时间光疗的新生儿,常规监测这些参数至关重要。